Background: TLE1 immunohistochemistry (IHC) is widely used as a biomarker of synovial sarcoma. Recently, we described moderate to strong TLE1 expression in 57% of dermal spindle cell melanomas with an additional 33% with weak expression. The utility of TLE1 IHC in melanoma has not been well described. The aim of this study was to investigate TLE1 expression in melanoma.
Δευτέρα 6 Αυγούστου 2018
Utility of TLE1 immunohistochemistry in melanoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: Available online 25 July 2018 Source: Journal of Photochemistry and Photobiology B: Biology Author(s): Marco Ballestr...
-
Editorial AJR Reviewers: Heartfelt Thanks From the Editors and Staff Thomas H. Berquist 1 Share + Affiliation: Citation: American Journal...
-
Publication date: Available online 28 September 2017 Source: Actas Dermo-Sifiliográficas Author(s): F.J. Navarro-Triviño
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.